重组人/食蟹猴VEGF165蛋白, HPLC-verified

Recombinant Human / Cynomolgus VEGF / VEGFA / VEGF165 Protein

Cat No: 11066‑HNAH｜Official product page:        https://cn.sinobiological.com/recombinant-proteins/human-vegfa-11066-hnah

Specifications

Alternate Names

Background

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF‑A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet‑derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide‑linked homodimer. VEGF‑A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF‑A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.

北京义翘神州科技股份有限公司作为国家高新技术企业，主要从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务，同时也为制药公司或者生物技术公司提供单克隆抗体候选药物的临床前规模生产服务。义翘神州拥有多项先进的核心技术以及从研发生产到放大生产的技术平台，为重组蛋白或者抗体试剂的高通量、高效率研发生产提供保障，旨在为全球制药企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。 北京义翘神州是入选科技部"现代服务创新发展示范企业"的唯一的一家生物技术企业，是北京市民营企业科技创新百强，获批北京市单克隆抗体技术重点实验室，多次承担国家科技部重大新药创制专项、863科技攻关项目和北京市科委项目。